Polymyositis following varicella and mumps infection in adults: report of two cases

Published: December 19 2023
Abstract Views: 1094
PDF: 378
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio, Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project , Reumatismo: Vol. 61 No. 1 (2009)
- V. Bruzzese, J. Pepe, Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab) , Reumatismo: Vol. 61 No. 4 (2009)
- D. Mohamadzadeh, S. Assar, F. Farsad, Acquired hemophilia A treated with rituximab in a 62-year-old female with rheumatoid arthritis: a case-based review , Reumatismo: Vol. 75 No. 4 (2023)
- B. Cremonezi Lammoglia, L. de Aguiar Trevise, T. Paslar Leal, M. Pereira Lopes Vieira Pinto, G. Hasselmann, N. Salles Rosa Neto, Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission , Reumatismo: Vol. 75 No. 4 (2023)
- M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini, Management of cutaneous discomfort in patients with scleroderma: a clinical trial , Reumatismo: Vol. 65 No. 5 (2013)
- B. Isci, T.S. Gamsiz, S. Kayipmaz, O. Keskin, M.E. Tezcan, Pulmonary cavitary lesions may be one of the presenting features in Ig A nephropathy , Reumatismo: Vol. 70 No. 2 (2018)
- T. Schioppo, L. Scalone, P. Cozzolino, L. Mantovani, G. Cesana, O. De Lucia, A. Murgo, F. Ingegnoli, Health-related quality of life burden in scleroderma patients treated with two different intravenous iloprost regimens , Reumatismo: Vol. 71 No. 2 (2019)
- L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita, Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis , Reumatismo: Vol. 61 No. 3 (2009)
- M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta, Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis , Reumatismo: Vol. 62 No. 4 (2010)
- G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta, GISEA: an Italian biological agents registry in rheumatology , Reumatismo: Vol. 63 No. 3 (2011)
You may also start an advanced similarity search for this article.